News + Seminars | N=1 Collaborative

top of page

Search

Illustrated Examples

N1C Preclinical Workgroup: Valuable Tools for the Preclinical Stage of Developing Potential Therapeutics

Click below for download

"Control of starting material quality for oligonucleotide therapeutics" and "To Synthesis and Beyond…Production of oligos for ‘N-of-1’ therapies"

Illustrated Examples

Community Job Openings

Welcome to our community job board where we curate relevant job openings to share with our community. If you have a job post to share, we...

Articles & Podcasts

Accelerated approval will be 'the norm' for gene therapies, FDA's Peter Marks says

Zachary Brennan (Endpoints News) February 27, 2027 The FDA will increasingly use accelerated approval for gene therapies aimed at rare...

Articles & Podcasts

Four Keys To Advancing Antisense Oligonucleotides For Personalized Medicine

Demaris Mills (Forbes) January 12, 2024 The 2023 Oligonucleotide Therapeutics Society meeting drew 800 attendees to Barcelona, a clear...

Connecting, Collaborating, Communicating, Challenges: Sharing experiences navigating family conversations in an n-of-1 investigational treatment setting

Patient Partners: Harnessing synergies to pursue ASOs as part of the AHC research portfolio

Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders

bottom of page